Seres therapeutics to host fourth quarter 2023 financial results and operational progress conference call and webcast on march 5, 2024

Cambridge, mass.--(business wire)--seres therapeutics, inc. (nasdaq: mcrb), a leading microbiome therapeutics company, today announced that management will host a conference call and live audio webcast on march 5, 2024 at 8:30 a.m. et to discuss fourth quarter and full year 2023 results and provide a general business update. to access the conference call, please dial 800-715-9871 (domestic) or 646-307-1963 (international) and reference the conference id number 4030622. to join the live webcast,.
MCRB Ratings Summary
MCRB Quant Ranking